Poland· PL-100444337
Pazopanib STADA
A pazopanib product containing pazopanibum, registered in Poland by STADA Arzneimittel AG. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Pazopanib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EX03 (pazopanib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Pazopanib · ATC L01EX03
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pazopanib costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pazopanib · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$87.69
The record
At a glance
URPL (Poland)- Active substance
- Pazopanibum
- Manufacturer
- STADA Arzneimittel AG
- Country
- Poland (PL)
- ATC code
- L01EX03
- ATC class
- Pazopanib
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991493202
- gtin05909991493219
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
593 interactions on record for pazopanib.
Graded by severity as the source publishes them — 155 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pazopanib · interactions on record
593 records
- 155 severe
- 428 moderate
- 10 minor
Most severe, free to view
- CimetidineA02BA01severe
- RanitidineA02BA02severe
- FamotidineA02BA03severe
- NizatidineA02BA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pazopanib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPAZOPANIB ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- FinlandPazopanib AccordAccord Healthcare B.V.
- NetherlandsPazopanib Accord 400 mg filmomhulde tablettenAccord Healthcare B.V.
- FrancePAZOPANIB ACCORD 400 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- SwedenPazopanib Accord 400 mg Filmdragerad tablettAccord Healthcare B.V.
- IrelandPazopanib Accord 400 mg film-coated tabletsAccord Healthcare Ireland Ltd.
- SpainPAZOPANIB ACCORD 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGAccord Healthcare S.L.U.
- BelgiumPazopanib Accord 400 mgAccord Healthcare
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Pazopanib Devatis
- Belgium · Pazopanib Accord, Pazopanib Eg
- Bulgaria · Алуниб, Пазопаниб G.L. Pharma
- Cyprus · Pazopanib Sapiens, Pazorem
- Czechia · Pazopanib Accord, Pazopanib Sandoz
- Germany · Pazopanib Al, Pazopanib Beta
- Denmark · Pazopanib Accord, Pazopanib Glenmark
- Estonia · Pazopanib Accord, Pazopanib Teva
- Spain · Pazopanib Accord, Pazopanib Dr. Reddys
- Finland · Pazopanib Accord, Pazopanib Glenmark
- France · Pazopanib Accord, Pazopanib Biogaran
- United Kingdom (Northern Ireland) · Pazopanib Accord, Pazopanib Accord Healthcare
- Greece · Pazopanib Accord, Pazopanib Stada
- Croatia · Pazopanib Accord, Pazopanib Frontier
- Hungary · Pazopanib Accord, Pazopanib G.L. Pharma
- Ireland · Pazopanib Accord, Pazopanib Reddy
- Iceland · Pazopanib Adalvo, Pazopanib Stada
- Italy · Pazopanib Accord, Pazopanib Dr. Reddy’s
- Liechtenstein · Votrient
- Lithuania · Pazopanib Accord, Pazopanib Auxilia
- Luxembourg · Pazopanib Eg, Pazopanib Pazopanib Eg
- Latvia · Pazopanib Accord, Pazopanib Teva
- Malta · Pazopanib Pharmacare, Pazopanib Pharos
- Netherlands · Pazopanib Accord, Pazopanib Cf
- Norway · Pazopanib Accord, Pazopanib Glenmark
- Portugal · Pazopanib Accord, Pazopanib Bluepharma
- Romania · Pazopanib Accord, Pazopanib Dr. Reddys
- Sweden · Pazopanib Accord, Pazopanib Glenmark
- Slovenia · Pazopanib Accord, Pazopanib Teva
- Slovakia · Pazopanib Accord, Pazopanib G.L. Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c65ef236-e3e6-4716-beba-d92dda164878 GET /v1/drugs/c65ef236-e3e6-4716-beba-d92dda164878?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "400 mg",
"packaging": "05909991493202 ¦ Rpz ¦ 146381\n30 tabl.\n05909991493219 ¦ Rpz ¦ 146382\n60 tabl.",
"substance": "Pazopanibi hydrochloridum 433.4 mg",
"common_name": "Pazopanibum",
"pl_product_id": "100444337",
"pozwolenie_nr": "27291",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about pazopanib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.